TuHURA Biosciences (HURA) EPS (Basic) (2010 - 2026)
TuHURA Biosciences' (HURA) quarterly EPS (Basic) came in at -$0.13 in Q1 2026, up 18.21% year-on-year from -$0.11 in Q1 2025, and up 10.98% quarter-over-quarter from -$0.14 in Q4 2025.
TuHURA Biosciences (HURA) EPS (Basic) (2010 - 2026) Analysis & Trends
TuHURA Biosciences' EPS (Basic) history runs 15 years deep, the most recent figure standing at -$0.13 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 18.21% year-over-year to -$0.13 in Q1 2026; TTM through Mar 2026 was -$0.52, a 33.07% increase from a year earlier, with the FY2025 full-year figure at -$0.63, up 48.32% from the prior year.
- EPS (Basic) advanced to -$0.13 in Q1 2026 per HURA's latest filing, from -$0.14 in the prior quarter.
- Across five years, EPS (Basic) topped out at $100.77 in Q2 2023 and bottomed at -$190.87 in Q1 2022.
- The 5-year median for EPS (Basic) is -$7.67 (2024), against an average of -$29.84.
- Across the five-year window, EPS (Basic) jumped 140313.24% in 2023 and tumbled 113.32% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$73.62 in 2022, then surged by 54.38% to -$33.59 in 2023, then surged by 68.74% to -$10.5 in 2024, then surged by 98.66% to -$0.14 in 2025, then gained by 10.98% to -$0.13 in 2026.
- Per Business Quant, the three latest HURA EPS (Basic) figures stand at -$0.13 (Q1 2026), -$0.14 (Q4 2025), and -$0.14 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 0.00 |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -2.29 |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | -0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.13 |
| Dec 31, 2025 | -0.14 |
| Sep 30, 2025 | -0.14 |
| Jun 30, 2025 | -0.21 |
| Mar 31, 2025 | -0.15 |
| Sep 30, 2024 | -10.50 |
| Jun 30, 2024 | -13.43 |
| Mar 31, 2024 | -4.85 |
| Dec 31, 2023 | -33.59 |
| Sep 30, 2023 | -63.91 |
| Jun 30, 2023 | 100.77 |
| Mar 31, 2023 | -68.00 |
| Dec 31, 2022 | -73.62 |
| Sep 30, 2022 | -118.58 |
| Jun 30, 2022 | -0.07 |
| Mar 31, 2022 | -190.87 |
| Dec 31, 2021 | -212.59 |
| Sep 30, 2021 | -430.37 |
| Jun 30, 2021 | -455.41 |
| Mar 31, 2021 | -397.14 |